newsfilter
← Latest News
Business Wire·

Acorda Therapeutics Announces Resignation of Chief Operating Officer

Acorda Therapeutics, Inc. (NASDAQ:ACOR) today announced that Lauren Sabella, Chief Operating Officer, will resign from the Company effective September 30, 2022. Ms. Sabella will be working in a strategic advisory role for early-stage biotechnology compa